Monday, April 20, 2020 6:38:56 PM
WHY:
CRIMINAL CEO!!
SEC FRAUD AND ILLEGAL STOCK MANIPULATION LAWSUIT!! SLAM DUNK FOR SEC!!
https://www.sec.gov/litigation/complaints/2018/comp24295.pdf
NO FILINGS FOR OVER THREE YEARS!!!
$64 MILLION DEFICIT!!
MASSIVE DEBT!!
MASSIVE LOSSES!!!
ZERO REVENUE!!
CONTINUALLY CAN'T EVEN PAY THEIR RENT!!
SEE ALL OF THE CEO'S (RIK) CRIMINAL ASSOCIATES BELOW!!
Phil Piccolo:
worldwidescam.com/sumphil.htm
http://patrickpretty.com/2014/04/27/mlm-watchdog-phil-piccolo-is-scamming-again/
SEAN PETER McMANUS:
https://structuredsettlements.typepad.com/structured_settlements_4r/2019/01/patriot-settlement-resources-mcmanus-sued-by-finra-for-selling-snake-oil-without-a-license.html
Waiora Lawsuit against Rik (Fake Ingredients/Fraud):
http://aprilmarietucker.com/wp-content/uploads/2013/05/Stanley-J.-Cherelstein-Waiora-lawsuit.pdf
https://www.law360.com/articles/922469/health-co-barred-from-selling-supplement-in-ip-row
Tommy Edward Crutchfield (Snake Guy in the video):
https://www.justice.gov/archive/opa/pr/1999/April/140enr.htm
Dr. Keith Gordon, DMV (Pet Pain Away Spokesperson):
https://www.mycentraljersey.com/story/news/local/middlesex-county/2015/12/28/fancy-pups-avenel-closed-owner-arrested/77981976/
COMPLAINT FOR PATENT INFRINGEMENT, BREACH OF LICENSE AGREEMENT, FRAUD AND RELATED CLAIMS (JURY DEMAND ENDORSED HEREON):
https://insight.rpxcorp.com/litigation_documents/2326309
Excerpt:
Rik’s FRAUD!!!:
22. Although Deitsch and NDA arranged to begin manufacture and sale of Product, they refused to inform Plaintiff, on later inquiries, of any manufacturing details, including the identity of the manufacturer. Case: 5:07-cv-00785-JG Doc #: 1 Filed: 03/16/07 8 of 16. PageID #: 62
-9-23.
Shortly after entering into the Agreement, NDA claimed to encounter problems with its marketing efforts in Germany. In a June 30, 2004, e-mail from his “nutrapharma” e-mail address, Deitsch informed Plaintiff of problems with “the German group” and the manufacturing of the Product.
Plaintiff now believes that no “German Division of MRI Labs” was available to NDA and that Deitsch misrepresented his German marketing infrastructure to induce Plaintiff to enter into the Agreement.
NUTRA PHARMA CORP.
Consolidated Statements of Operations
For the Years Ended
December 31,
2017 2016
Net sales $ 120,979 168,356
Cost of sales 38,965
Impairment of inventory - 184,039
Gross profit (54,648)
Operating expenses:
Selling, general and administrative - including stock based compensation of $73,576 and $390,608 for the years ended December 31, 2017 and 2016, respectively 1,476,016 1,988,868
Total operating expenses 1,476,016 1,988,868
Loss from operations (1,381,940) (2,043,516)
Other (income) expenses
Rental income - 19,381
Interest expense (358,651) (293,785)
Change in fair value of derivatives (2,273,968) (1,258,649)
Gain (Loss) on settlement of indebtedness, net (14,189) 128,956
Other expenses (2,646,808) (1,404,097)
Net loss before income taxes (4,028,748)
Provision for income taxes - -
Net loss (4,028,748) (3,447,613)
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM